STAT

A new bill would let more doctors prescribe addiction treatments without waiting for insurers’ permission

Fewer doctors would have to wait for permission to prescribe addiction treatment drugs under a new, bipartisan bill.
Under a new bill co-authored by Rep. Paul Tonko (D-N.Y.), the practice of “prior authorization” would be banned in state Medicaid programs for addiction treatment medicines like buprenorphine.

WASHINGTON — Fewer doctors would have to wait for permission to prescribe addiction treatment drugs under new, bipartisan legislation being unveiled this week by two lawmakers on the House Energy and Commerce Committee.

Under a new bill authored by Reps. Paul Tonko (D-N.Y.) and David McKinley (R-W.Va.), the practice of “prior authorization,” in which insurers require doctors to seek approval before they can proceed with a prescription or

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks